| 2014 |
ITPR2 mediates calcium release from the endoplasmic reticulum (ER) to the mitochondria during oncogene-induced senescence (OIS) and replicative senescence; mitochondrial calcium accumulation via MCU leads to decreased mitochondrial membrane potential, ROS accumulation, and senescence. Loss-of-function screen identified ITPR2 and MCU as senescence regulators, and loss of either enabled escape from OIS. |
Loss-of-function genetic screen; siRNA knockdown; live-cell calcium imaging; mitochondrial membrane potential assays |
Nature communications |
High |
24797322
|
| 2021 |
ITPR2 drives cellular senescence and aging by mediating ER-to-mitochondria calcium transfer; Itpr2 knockout mice display increased lifespan, less senescence, fewer mitochondria-ER contacts, and forced ER-mitochondria contacts in vitro induce premature senescence. Ablation of ITPR2 decreases the number of mitochondria-ER contact sites both in vivo and in vitro. |
Itpr2 knockout mouse model; transmission electron microscopy of MAM contacts; lifespan assays; in vitro forced ER-mitochondria contact experiments; cellular senescence assays |
Nature communications |
High |
33526781
|
| 2015 |
In astrocytes, IP3R2 is the primary receptor responsible for GPCR-dependent somatic Ca2+ signals. Ip3r2-/- mice lack somatic Ca2+ fluctuations in astrocytes but retain diverse Ca2+ fluctuations in astrocyte processes and end feet that are preserved and can be increased by GPCR activation and neuromodulatory (startle) responses. |
Two-photon Ca2+ imaging in brain slices and in vivo; Ip3r2-/- knockout mice; GPCR pharmacological stimulation |
Nature neuroscience |
High |
25894291
|
| 2013 |
IP3R2 protein levels dictate apoptotic sensitivity to disruption of IP3R/Bcl-2 complexes in diffuse large B-cell lymphoma cells; Bcl-2 suppresses IP3R2 hyperactivity, and disrupting the IP3R2/Bcl-2 complex with TAT-IDP(S) peptide promotes IP3-induced pro-apoptotic Ca2+ signaling. Knocking down IP3R2 reduced TAT-IDP(S)-induced apoptosis and Ca2+ release. |
siRNA knockdown of IP3R2; pharmacological inhibition with xestospongin C; Ca2+ imaging; apoptosis assays; correlation of IP3R2 protein levels with apoptotic responses across multiple cell lines |
Cell death & disease |
High |
23681227
|
| 2016 |
ERP44 inhibits lung cancer cell migration primarily via IP3R2; ERP44 overexpression reduces intracellular Ca2+ release through IP3Rs and inhibits cell polarization and pseudopodium protrusion. siRNA knockdown of IP3R2 (but not IP3R1 or IP3R3) markedly inhibited wound healing, establishing IP3R2 as the isoform-specific mediator. |
siRNA knockdown of IP3R1, IP3R2, IP3R3 (isoform-specific comparison); ERP44 overexpression; Ca2+ imaging; wound-healing migration assay; cell morphology analysis |
Aging |
Medium |
27347718
|
| 2022 |
PFOS-induced early insulin resistance involves formation of an IP3R2-VDAC1-MICU1 complex at the ER-mitochondria interface. Detyrosinated α-tubulin, which increases in an autophagy-dependent manner, interacts with VDAC1 and enhances assembly of this IP3R2-VDAC1-MICU1 complex, promoting mitochondrial Ca2+ overload. Inhibiting autophagy relieved mitochondrial Ca2+ overload and reversed IR. |
Co-immunoprecipitation (IP3R2-VDAC1-MICU1 complex); siRNA knockdown; autophagy inhibitors; Ca2+ imaging; in vitro (L-02 cells) and in vivo (C57BL/6J mice) models |
The Science of the total environment |
Medium |
35192817
|
| 2025 |
FMO2 localizes to MAM structures where it binds IP3R2 as a component of the IP3R2-Grp75-VDAC1 complex, maintaining ER-mitochondria contact and regulating mitochondrial Ca2+ signaling for bioenergetics. Deletion or overexpression of FMO2 bidirectionally modulates pathological cardiac hypertrophy progression, and a synthetic peptide enhancing ER-mitochondria contact promoted Ca2+ transfer and prevented hypertrophy. |
MAM-targeted mass spectrometry; Co-immunoprecipitation; genetic mouse models (FMO2 KO and overexpression); AAV9-mediated cardiac overexpression; neonatal rat cardiomyocyte culture |
Circulation |
Medium |
40489543
|
| 2024 |
IP3R2-mediated ER Ca2+ release activates the NLRP3/Caspase-1/GSDMD pyroptosis pathway in cardiomyocytes in response to LPS; siRNA knockdown of IP3R2 or pharmacological inhibition with xestospongin C reversed LPS-induced intracellular Ca2+ release and suppressed pyroptosis. Mutual regulation between ER stress and IP3R2-mediated Ca2+ release amplifies this pathway. |
siRNA knockdown of IP3R2; pharmacological inhibition (xestospongin C, MCC950); Ca2+ imaging; Western blot for NLRP3/Caspase-1/GSDMD; in vivo rat LPS model |
Cell death discovery |
Medium |
38378646
|
| 2024 |
Loss of ITPR2 in oligodendrocytes disturbs Ca2+ homeostasis, inhibits myelination, and disrupts OPC proliferation/differentiation via the MAPK/ERK-CDK6/cyclin D1 axis. Itpr2 ablation elevates resting [Ca2+]i in OPCs through compensatory upregulation of plasma membrane calcium channels; antagonists against these channels normalize [Ca2+]i and enhance OPC lineage progression. |
Oligodendrocyte-specific Itpr2 conditional knockout mice; transcriptome profiling; Ca2+ imaging; MAPK/ERK pathway inhibition; pharmacological antagonism of plasma membrane Ca2+ channels |
Advanced science |
Medium |
38476116
|
| 2021 |
Itpr2 (IP3R2) deficiency in mice causes a developmental delay in oligodendrocyte differentiation, resulting in an increased percentage of CAII+ type I/II oligodendrocytes that preferentially myelinate small-diameter axons, leading to abnormal compound action potentials in optic nerves. |
Conventional and conditional Itpr2 knockout mice; immunohistochemistry; electrophysiology (CAP recordings in optic nerves); histological analysis |
Frontiers in cellular neuroscience |
Medium |
34630045
|
| 2024 |
IP3R2-enriched MAMs are increased in photoreceptors under hypoxia; elevated IP3R2 at MAMs leads to mitochondrial calcium overload and apoptosis. IP3R2 knockdown improved mitochondrial morphology and function by limiting MAM formation and attenuating mitochondrial Ca2+ overload. |
siRNA knockdown; transmission electron microscopy; ER-mitochondria colocalization; MAM reporter; flow cytometry; in vivo subretinal injection model |
Experimental eye research |
Medium |
38851477
|
| 2022 |
BMAL1 directly regulates the transcription of ITPR2 (and ITPR3); loss of BMAL1 downregulates ITPR2/3 expression and causes vacuolation, atrophy, and secretory dysfunction in lacrimal and parotid acinar cells. Restoration of ITPR2 and ITPR3 expression in Bmal1-deficient rats alleviated symptoms of secretory dysfunction. |
Bmal1 knockout rats; ITPR2/ITPR3 rescue experiments (adenoviral re-expression); ChIP or transcriptional analysis of BMAL1 binding to ITPR2/3 promoters; secretion assays |
The ocular surface |
Medium |
39343166
|
| 2024 |
miR-129 directly represses ITPR2 expression and controls ER-to-mitochondria calcium transfer, mitochondrial membrane potential, ROS, DNA damage, and cellular senescence through the ITPR2-MCU axis. Overexpression of miR-129 delayed bleomycin-induced cellular and lung aging in mice. |
miRNA target validation (luciferase reporter or direct binding assay implied); miR-129 overexpression and inhibition; Ca2+ imaging; ROS and MMP assays; in vivo bleomycin lung aging model |
Mechanisms of ageing and development |
Medium |
38218462
|
| 2022 |
DPP4 (nonenzymatic function) activates PKA/SP1 signaling via IGF2R binding, which upregulates ERp29 expression; ERp29 binds IP3R2, inhibiting its degradation and promoting MAM formation and mitochondrial Ca2+ overload in Treg cells, impairing Treg function and driving M1 microglia polarization. |
Co-immunoprecipitation (ERp29-IP3R2); IGF-2R knockdown/blockade; in vivo db/db mouse model; in vitro Treg assays; DPP4 enzymatic-site mutation |
Metabolism: clinical and experimental |
Medium |
36302455
|
| 2018 |
The IP3-binding core (IBC) domain of human IP3R2 (residues 224-604) binds IP3 with high affinity and undergoes conformational changes in secondary and tertiary structure upon IP3 binding, as detected by far-CD and intrinsic fluorescence spectroscopy. Key conserved ligand-binding residues identified by bioinformatics include R269, K508, and R511. |
Molecular cloning and bacterial expression of IBC domain; CD spectroscopy; intrinsic fluorescence spectroscopy; bioinformatics of binding-site residues |
International journal of biological macromolecules |
Low |
30244130
|
| 2020 |
Knockdown of Tcirg1 decreases IP3R2 expression in osteoclast precursors, reducing intracellular Ca2+ levels and limiting nuclear translocation of NFATc1, thereby inhibiting large osteoclast (>100 µm) generation during RANKL-induced differentiation. |
Lentiviral shRNA knockdown of Tcirg1 in mouse bone marrow-derived monocytes; NFATc1 nuclear translocation assay; Ca2+ imaging; osteoclast differentiation assay |
PloS one |
Low |
32790690
|
| 2025 |
FUNDC1 binds directly to IP3R2 at MAMs (confirmed by Co-IP); in cardiac hypertrophy, FUNDC1 binding to IP3R2 regulates MAM-associated Ca2+ overload, inducing mitochondrial dysfunction and pyroptosis. FUNDC1 knockdown promotes IP3R2 ubiquitination and degradation, reducing mitochondrial Ca2+ and protecting against hypertrophy. |
Co-immunoprecipitation (FUNDC1-IP3R2); siRNA knockdown and overexpression of FUNDC1; spontaneously hypertensive rat model; flow cytometry for mitochondrial Ca2+; mitochondrial function assays |
Life sciences |
Medium |
40451326
|
| 2025 |
IP3R2 knockdown decreases mitochondrial Ca2+ uptake, augments the ADP/ATP ratio, and activates melanophagy via the AMPK-ULK1 pathway. Simultaneously, IP3R2 silencing increases ER-lysosome proximity, elevates lysosomal Ca2+ levels, reduces lysosomal pH, activates lysosomal TRPML1 channel, and stimulates nuclear translocation of TFEB, transcriptionally upregulating melanophagy genes. IP3R2 (but not IP3R1 or IP3R3) is a negative regulator of melanophagy, confirmed in zebrafish in vivo. |
siRNA knockdown (isoform-specific: IP3R1, IP3R2, IP3R3 compared); ratiometric live-cell imaging probes for melanophagy; Ca2+ imaging (mitochondrial, lysosomal); TFEB nuclear translocation assay; TRPML1 channel activity; in vivo zebrafish pigmentation model |
bioRxivpreprint |
Medium |
|
| 2025 |
Loss of astrocytic IP3R2 leads to deficits in maturation of glutamatergic (but not GABAergic) synapses in the mouse visual cortex, accompanied by attenuated visually evoked neuronal activation and impaired behavioral responses to visual threat stimuli. Astrocyte morphological complexity is also diminished in the absence of IP3R2. |
IP3R2 knockout mouse; histological synapse quantification; electrophysiology (visually evoked responses); behavioral visual threat assay; astrocyte morphology analysis |
bioRxivpreprint |
Low |
|
| 2012 |
Deletion of IP3R2 (IP3-R(2)-/-) did not alter the progression of dilated cardiomyopathy (DCM) or pressure overload hypertrophy in mouse models, despite increased IP3R2 expression and elevated IP3 levels in both disease states. Cardiac chamber dimensions, electrophysiology, contractility, lung congestion, and mortality were unchanged in DCM-2Tg mice with or without IP3R2. |
Genetic cross of DCM-2Tg with IP3-R(2)-/- mice; transverse aortic constriction on IP3-R(2)-/- mice; echocardiography; electrophysiology; histopathology |
Circulation. Heart failure |
Medium |
23258573
|
| 2014 |
IP3R2 conditional knockout mice show no change in behavioral tests including anxiety, depression, motor/sensory function, or spatial memory (Morris water maze), indicating that astrocytic IP3R2-mediated Ca2+ signaling is not a major modulator of these behavioral processes. |
IP3R2 conditional knockout mouse; battery of behavioral tests (anxiety, depression, motor, sensory, Morris water maze) |
Frontiers in behavioral neuroscience |
Medium |
25429263
|